Novel Technologies for Respiratory Virus Identification

Launched by PORTSMOUTH HOSPITALS NHS TRUST · Dec 13, 2022

Keywords

ClinConnect Summary

This clinical trial is studying a new technology called the OxDx system, which is designed to quickly and accurately identify respiratory viruses from samples taken from the nose or throat. This is important because current methods can take a long time and may not always be reliable or affordable. The goal is to train this system to recognize different viruses by collecting samples from patients who show signs of a respiratory viral infection, such as a runny nose, cough, sore throat, or fever.

The trial will take place at Portsmouth Hospitals University NHS Trust and aims to recruit around 1,000 participants, including both adults and children. To participate, individuals must consent (or have a parent or guardian consent for them, if they are children) and have symptoms that suggest a respiratory virus. Participants will have a nasal or throat swab taken, which will help improve the accuracy of the OxDx system. It’s important to note that any test results from this study will not be shared with patients or their healthcare teams, and they will not affect their care. The collected information will be kept secure and will help researchers refine this new technology for future use.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Provide informed, (parental/guardian, where appropriate) consent
• • Able to provide nasopharyngeal swab/aspirate specimens.
• * A clinical suspicion of a respiratory viral infection with one or more of the following symptoms:
• • Coryzal symptoms (runny nose, sneezing and/or nasal congestion)
• • New onset of cough
• • Sore throat
• • Head and/or Muscle aches
• • Fever or chills
• Exclusion Criteria:
• • Unable to comply with study procedures or where in the opinion of the investigator, undertaking a nasopharyngeal swab may be detrimental to the individual
• • Lacking capacity to consent

Trial Officials